PSY28 Cost-Effectiveness Analysis of Celecoxib in the Treatment of Chronic Pain in Patients With Osteoarthritis or Rheumatoid Arthritis Versus the Use of Etoricoxib or Lumiracoxib in Mexico
Abstract
Authors
J.J. Vargas-valencia R. Orrantia-Gradín E. Muciño-Ortega R.M. Galindo-Suárez